Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09WUP
|
||||
Former ID |
DNC008645
|
||||
Drug Name |
3,7-Bis(2-hydroxyethyl)icaritin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529676] | ||
Structure |
Download2D MOL |
||||
Formula |
C25H28O8
|
||||
Canonical SMILES |
CC(=CCC1=C(C=C(C2=C1OC(=C(C2=O)OCCO)C3=CC=C(C=C3)OC)O)O<br />CCO)C
|
||||
InChI |
1S/C25H28O8/c1-15(2)4-9-18-20(31-12-10-26)14-19(28)21-22(29)25(32-13-11-27)23(33-24(18)21)16-5-7-17(30-3)8-6-16/h4-8,14,26-28H,9-13H2,1-3H3
|
||||
InChIKey |
WTJGVHRGWYENBZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CGMP-specific 3',5'-cyclic phosphodiesterase | Target Info | Inhibitor | [529676] | |
KEGG Pathway | Purine metabolism | ||||
cGMP-PKG signaling pathway | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Reactome | cGMP effects | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.